StonvexLoading…
StonvexStonvexStonvexCore line items from BTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $614.85M | $498.82M | $336.33M | $164.23M |
Operating Income | $41.21M | $45.33M | $33.55M | $17.80M |
Net Income | $-6.18M | $15.81M | $10.26M | $4.19M |
EPS (Diluted) | $-0.86 | $0.37 | $0.35 | $0.20 |
Total Assets | $130.57M | $125.28M | $109.05M | $89.72M |
Total Liabilities | $119.16M | $104.26M | $104.36M | $94.31M |
Cash & Equivalents | $65.63M | $59.27M | $48.04M | $34.96M |
Free Cash Flow OCF − CapEx | $28.49M | $28.18M | $25.63M | $15.87M |
Shares Outstanding | 7.15M | 42.17M | 29.41M | 21.36M |